ATE291575T1 - N-carbamoyloxyalkyl-substituierte azolium- verbindungen - Google Patents

N-carbamoyloxyalkyl-substituierte azolium- verbindungen

Info

Publication number: ATE291575T1
Authority: AT; Austria
Prior art keywords: carbamoyloxyalkyl; substituted; azolium compounds; compounds; substituted azolium
Prior art date: 1999-11-02

Application number

AT00992946T

Other languages

English (en)

Inventor

Hiroshi Fukuda

Tadakatsu Hayase

Eisaku Mizuguchi

Nobuo Shimma

Jun Ohwada

Nobuhiro Oikawa

Masahiro Sakaitani

Masao Tsukazaki

Isao Umeda

Original Assignee

Basilea Pharmaceutica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-02

Filing date

2000-10-25

Publication date

2005-04-15

2000-10-25 Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag

2005-04-15 Application granted granted Critical

2005-04-15 Publication of ATE291575T1 publication Critical patent/ATE291575T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cephalosporin Compounds (AREA)

AT00992946T 1999-11-02 2000-10-25 N-carbamoyloxyalkyl-substituierte azolium- verbindungen ATE291575T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99121694		1999-11-02
PCT/EP2000/010524 WO2001032652A2 (en)	1999-11-02	2000-10-25	N-substituted carbamoyloxyalkyl-azolium derivatives

Publications (1)

Publication Number	Publication Date
ATE291575T1 true ATE291575T1 (de)	2005-04-15

Family

ID=8239312

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00992946T ATE291575T1 (de)	1999-11-02	2000-10-25	N-carbamoyloxyalkyl-substituierte azolium- verbindungen

Country Status (22)

Country	Link
EP (1)	EP1280795B1 (de)
JP (1)	JP3787307B2 (de)
KR (1)	KR100449797B1 (de)
CN (1)	CN1185230C (de)
AR (1)	AR029403A1 (de)
AT (1)	ATE291575T1 (de)
AU (1)	AU777859B2 (de)
BE (1)	BE2016C007I2 (de)
BR (1)	BRPI0015254C1 (de)
CA (2)	CA2680292C (de)
CY (1)	CY2016002I1 (de)
DE (1)	DE60018989T2 (de)
DK (1)	DK1280795T3 (de)
ES (1)	ES2238341T3 (de)
FR (1)	FR15C0096I2 (de)
LU (1)	LU92939I2 (de)
MX (1)	MXPA02004145A (de)
NL (1)	NL300791I1 (de)
PT (1)	PT1280795E (de)
TR (1)	TR200201205T2 (de)
WO (1)	WO2001032652A2 (de)
ZA (1)	ZA200203003B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY148805A (en)	2002-10-16	2013-05-31	Takeda Pharmaceutical	Controlled release preparation
KR101493546B1 (ko)	2007-08-21	2015-02-16	바실리어 파마슈티카 아게	항균 조성물
EA032840B8 (ru)	2011-06-22	2020-06-18	Вайоми Терапеутикс Лимитед	Пролекарства на основе конъюгатов противогрибковых агентов и их применение
EA201592236A1 (ru)	2013-06-04	2016-06-30	Вайом Байосайнсиз Пвт. Лтд.	Частицы с нанесенным покрытием и композиции, включающие такие частицы
CN104230894B (zh) *	2013-06-06	2016-08-24	南京华威医药科技开发有限公司	三唑类化合物
CA2972401C (en) *	2014-12-30	2023-09-05	Dow Agrosciences Llc	Picolinamide compounds with fungicidal activity
CN106032356B (zh) *	2015-03-13	2018-09-14	江苏正大丰海制药有限公司	一种[n-甲基-吡啶-2-基]氨基甲酸-1-氯乙酯的制备方法
CN104974143A (zh) *	2015-05-12	2015-10-14	深圳致君制药有限公司	一种季铵盐类化合物、其制备方法以及用途
CN106467534B (zh) *	2015-08-17	2019-10-11	江苏奥赛康药业有限公司	一种硫酸艾沙康唑鎓化合物及其药物组合物
CN106467519B (zh) *	2015-08-17	2019-08-13	南京华威医药科技集团有限公司	一种水溶性三唑化合物
CN106565699B (zh) *	2015-10-10	2019-07-26	江苏正大丰海制药有限公司	一种艾沙康唑硫酸盐晶体及其制备方法
US10683387B2 (en)	2016-10-04	2020-06-16	Massachusetts Institute Of Technology	Bottlebrush copolymers and uses thereof
WO2018149359A1 (zh) *	2017-02-17	2018-08-23	武汉朗来科技发展有限公司	三氮唑抗菌衍生物、其药物组合物和用途
CN106916152B (zh) *	2017-04-27	2019-09-17	扬子江药业集团有限公司	氧化还原反应制备艾沙康唑鎓单硫酸盐的方法
WO2019006426A2 (en)	2017-06-30	2019-01-03	Massachusetts Institute Of Technology	RAMIFIED MULTIFUNCTIONAL MACROMONOMERS AND RELATED POLYMERS AND USES THEREOF
WO2019006425A1 (en)	2017-06-30	2019-01-03	Massachusetts Institute Of Technology	IMAGING AGENTS OF BRUSH ARRAY STAR POLYMERS AND USES THEREOF
US10368502B2 (en)	2017-09-25	2019-08-06	Multiple Energy Technologies Llc	Bioceramic and carbon-based hydroponic systems, methods and devices
CN110317165A (zh) *	2018-03-28	2019-10-11	上海医药工业研究院	一种药物中间体2-甲胺基-3-吡啶甲醇的制备方法
CN110551064B (zh) *	2018-06-01	2021-01-01	重庆世森医药科技有限公司	艾沙康唑硫酸酯及其中间体的制备方法
MX2021001116A (es)	2018-08-01	2021-03-31	Basilea Pharm Int Ag	Metodos para purificar sulfato de isavuconazonio.
US10988491B2 (en)	2018-08-17	2021-04-27	Massachusetts Institute Of Technology	Degradable polymers of a cyclic silyl ether and uses thereof
CN110128420A (zh) *	2019-05-08	2019-08-16	阴启明	硫酸氢根/硫酸根型阴离子交换技术制备艾沙康唑鎓单硫酸盐的方法
EP4021576A1 (de)	2019-08-26	2022-07-06	Synthon B.V.	Isavuconazoniumsalze und verfahren zur herstellung davon
EP4045562A2 (de) *	2019-10-16	2022-08-24	Massachusetts Institute of Technology	Brush-prodrugs und verwendungen davon
WO2021141662A1 (en)	2020-01-10	2021-07-15	Massachusetts Institute Of Technology	Proteolysis targeting chimeric molecules (protacs) with functional handles and uses thereof
JP7570382B2 (ja)	2021-09-28	2024-10-21	旭化成ファーマ株式会社	エアベント付き輸液フィルタを備える点滴静脈投与用輸液セット
JP7454905B2 (ja) *	2021-09-28	2024-03-25	旭化成ファーマ株式会社	有効成分であるイサブコナゾール又はそのプロドラッグを含有する真菌症治療及び／又は予防剤
WO2023121753A1 (en)	2021-12-20	2023-06-29	Massachusetts Institute Of Technology	Biomolecule-polymer-pharmaceutical agent conjugates for delivering the pharmaceutical agent
EP4289840A1 (de)	2022-06-07	2023-12-13	Zaklady Farmaceutyczne Polpharma S.A.	Ein verfahren zur herstellung von isavuconazoniumsulfat
WO2024094329A1 (en)	2022-11-01	2024-05-10	Basilea Pharmaceutica International Ag, Allschwil	Blister-packaged capsule preparation containing isavuconazonium sulfate
WO2024189550A1 (en) *	2023-03-13	2024-09-19	Apitoria Pharma Private Limited	Process for the preparation of isavuconazonium sulfate and its crystalline forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6520098A (en) *	1997-03-31	1998-10-22	Takeda Chemical Industries Ltd.	Azole compounds, their production and their use
JP3108997B2 (ja) *	1997-03-31	2000-11-13	武田薬品工業株式会社	アゾール化合物、その製造法および用途
AU2931399A (en) *	1998-03-06	1999-09-20	F. Hoffmann-La Roche Ag	3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity

2000
- 2000-10-25 DE DE60018989T patent/DE60018989T2/de not_active Expired - Lifetime
- 2000-10-25 WO PCT/EP2000/010524 patent/WO2001032652A2/en active Search and Examination
- 2000-10-25 EP EP00992946A patent/EP1280795B1/de not_active Expired - Lifetime
- 2000-10-25 CN CNB008153299A patent/CN1185230C/zh not_active Expired - Lifetime
- 2000-10-25 AU AU28352/01A patent/AU777859B2/en active Active
- 2000-10-25 CA CA2680292A patent/CA2680292C/en not_active Expired - Lifetime
- 2000-10-25 CA CA002388320A patent/CA2388320C/en not_active Expired - Lifetime
- 2000-10-25 TR TR2002/01205T patent/TR200201205T2/xx unknown
- 2000-10-25 ES ES00992946T patent/ES2238341T3/es not_active Expired - Lifetime
- 2000-10-25 PT PT00992946T patent/PT1280795E/pt unknown
- 2000-10-25 MX MXPA02004145A patent/MXPA02004145A/es active IP Right Grant
- 2000-10-25 AT AT00992946T patent/ATE291575T1/de active
- 2000-10-25 BR BRPI0015254A patent/BRPI0015254C1/pt not_active IP Right Cessation
- 2000-10-25 KR KR10-2002-7005574A patent/KR100449797B1/ko active Protection Beyond IP Right Term
- 2000-10-25 JP JP2001534803A patent/JP3787307B2/ja not_active Expired - Lifetime
- 2000-10-25 DK DK00992946T patent/DK1280795T3/da active
- 2000-10-31 AR ARP000105739A patent/AR029403A1/es active IP Right Grant
2002
- 2002-04-16 ZA ZA200203003A patent/ZA200203003B/xx unknown
2015
- 2015-12-29 FR FR15C0096C patent/FR15C0096I2/fr active Active
2016
- 2016-01-06 LU LU92939C patent/LU92939I2/xx unknown
- 2016-01-26 NL NL300791C patent/NL300791I1/nl unknown
- 2016-02-03 CY CY2016002C patent/CY2016002I1/el unknown
- 2016-02-26 BE BE2016C007C patent/BE2016C007I2/fr unknown

Also Published As

Publication number	Publication date
BRPI0015254B8 (pt)	2017-04-25
CA2680292C (en)	2012-11-27
NL300791I2 (de)	2016-03-15
BR0015254B1 (pt)	2013-05-21
PT1280795E (pt)	2005-06-30
FR15C0096I1 (de)	2016-02-12
WO2001032652A3 (en)	2001-11-15
FR15C0096I2 (fr)	2016-04-22
CN1387529A (zh)	2002-12-25
CY2016002I2 (el)	2016-10-05
AU2835201A (en)	2001-05-14
EP1280795B1 (de)	2005-03-23
AR029403A1 (es)	2003-06-25
ES2238341T3 (es)	2005-09-01
CY2016002I1 (el)	2016-10-05
DK1280795T3 (da)	2005-07-18
LU92939I2 (fr)	2016-03-07
DE60018989D1 (de)	2005-04-28
CA2680292A1 (en)	2001-05-10
MXPA02004145A (es)	2002-10-17
NL300791I1 (de)	2016-03-15
DE60018989T2 (de)	2005-08-18
CA2388320A1 (en)	2001-05-10
TR200201205T2 (tr)	2002-08-21
EP1280795A2 (de)	2003-02-05
BE2016C007I2 (de)	2019-10-23
ZA200203003B (en)	2003-09-23
KR100449797B1 (ko)	2004-09-30
JP2003513090A (ja)	2003-04-08
BR0015254A (pt)	2002-06-25
BRPI0015254C1 (pt)	2021-05-25
WO2001032652A2 (en)	2001-05-10
CN1185230C (zh)	2005-01-19
JP3787307B2 (ja)	2006-06-21
KR20020062298A (ko)	2002-07-25
AU777859B2 (en)	2004-11-04
ES2238341T9 (es)	2016-03-02
CA2388320C (en)	2009-12-15

Publication	Publication Date	Title
ATE291575T1 (de)	2005-04-15	N-carbamoyloxyalkyl-substituierte azolium- verbindungen
DK1224180T3 (da)	2003-10-20	Substituerede azoler
EE200100502A (et)	2002-12-16	Ühendid
EE200200033A (et)	2003-02-17	Uued ühendid
ITMI992711A0 (it)	1999-12-27	Composti organici
NO20016115L (no)	2002-02-12	Substituerte heterosykelkondenserte gamma-karbolin
EE200200224A (et)	2003-06-16	Uudsed ühendid
IS6139A (is)	2001-11-01	Ný efnasambönd
ID29533A (id)	2001-09-06	Senyawa-senyawa kalsilitik
NO20020466L (no)	2002-03-20	Kalsilytiske forbindelser
IS6141A (is)	2001-11-01	Ný efnasambönd
NO20014262D0 (no)	2001-09-03	Tiazoloindolinon-forbindelser
NO20022927D0 (no)	2002-06-18	Substituerte pyrrazoler
ID29984A (id)	2001-10-25	Senyawa-senyawa bis-stirilbifenil
DK1200423T3 (da)	2003-12-22	Substituerede pehnyluraciler
SE9904420D0 (sv)	1999-12-03	New compounds
SE9904422D0 (sv)	1999-12-03	New compounds
SE9900071D0 (sv)	1999-01-13	New compounds
SE9900086D0 (sv)	1999-01-14	New compounds
SE9902762D0 (sv)	1999-07-21	New compounds
SE9904228D0 (sv)	1999-11-22	New compounds
SE9904418D0 (sv)	1999-12-03	New compounds
SE9901117D0 (sv)	1999-03-26	Novel compounds
SE9901118D0 (sv)	1999-03-26	Novel compounds
SE9901271D0 (sv)	1999-04-09	Novel compounds

Legal Events

Date	Code	Title	Description
2005-11-15	UEP	Publication of translation of european patent specification	Ref document number: 1280795 Country of ref document: EP

Date

Code

Title

Description

2005-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1280795

Country of ref document: EP